CYIOS Corp's Wholly Owned Subsidiary Choice Wellness

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams Lee Adams #97
444
CYIOS Corp's Wholly Owned Subsidiary Choice Wellness Officially Launches New Online Store for Its DR's CHOICE CBD and "24" Hand Sanitizer Brands

Aventura, Florida--(Newsfile Corp. - June 19, 2020) - CYIOS Corp (OTC Pink: CYIO), a publicly traded company focused on developing and marketing specialty branded products in the Health and Wellness markets, is pleased to announce it has launched its new online-retail web platform at www.choicewellnessbrands.com. Concurrent with the launch is a social media and marketing campaign aimed at product awareness and driving traffic to the site. The Company will also be utilizing the Cicero Transact data base as part of its ongoing marketing plans.

Mr. O'Shea Chiarman of CYIOS Corp. commented, "We are very pleased to have launched our new online retail store and happy to report the expansion of our product offerings to include; DR's CHOICE brand of CBD topicals and tinctures, 24 HAND SANITIZER, and other wellness products including KN-95 face masks, infrared non-contact hand held thermometer, and soon to be released Personal Protection Equipment including Level 1 Isolation Gowns, Full Face plastic shields for medical professionals and Doctors on the front line. The first run of our 24 HAND SANITIZER will be packaged in 2oz tubes at a FDA registered facility that will also be handling all of our fulfillment with anticipated shipping availability in 1-2 weeks. Sales have already commenced with some larger orders and we are confident our new products, new online store and product marketing efforts will generate strong interest from retail consumers and from various industries seeking better and more effective sanitizing solutions.


"24" Hand Sanitizer

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7058/58...01full.jpg

The Problem in a pandemic is that harmful germs are everywhere, and consumers need to be educated that alcohol-based sanitizer is not the best long-term solution. Alcohol-based sanitizer products provide a one-time kill and only last for 1-2 minutes per use or until hands have dried. Once dried, you have no further protection against harmful germs and re-contamination as you venture out in public, head to work, and/or conduct daily routine. Alcohol can be absorbed into skin and is toxic if ingested which is not good if you have children to protect. Alcohol sanitizer stings if there is any skin abrasion on hands and must be used over and over all day, every day to combat germs while out in public. Typical thick alcohol sanitizer gel takes longer to dry, dries out skin and changes your skin's natural PH.

The Solution: 24 HAND SANITIZER kills 99.99% of germs, is alcohol-free and formulated & enhanced with Zetrisil®. Zetrisil® is a nano antimicrobial technology that creates a shield of protection on your hands and provides persistent long-lasting protection that helps prevent re-contamination of harmful germs that your hands may come into contact with from your daily routine, workplace and/or out in public. The fast acting, quick drying formula leaves hands soft and smooth, is safe for children and contains NO ALCOHOL = Non flammable, Non-toxic AND NO STING! Importantly, 24 is more economical than traditional alcohol-based products due to lower overall usage need per day and per month. AND, it's MADE IN THE USA!

Mr. O'Shea went on to say, "Unlike alcohol based sanitizer, there is some unique science behind 24 HAND SANITIZER. The physical kill of germs is accomplished by the active ingredient Benzolkonium Chloride which is one of only three (and the only one that is non-alcohol) active ingredients allowed by the FDA for use in hand sanitizer. 24 HAND SANITIZER is formulated and enhanced with Zetrisil®. Zetrisil® is a proprietary nano-based silicone compound which effectively protects and/or "shields" the area that 24 HAND SANITIZER is applied to from bacterial contamination by way of a long-lasting, cationic-charged, anti-microbial nano-silicone coating. In other words, Zetrisil® creates a shield of protection on your hands and provides persistent activity that helps prevent re-contamination of harmful germs that your hands may come into contact with in between washings, while at work, and/or while out in public. As Governments, States and Cities continue to open, giving rise to new pandemic cases, we feel it's important to offer a safer alternative to alcohol based sanitizers and to provide a hand sanitizing solution that can give people some confidence and a little peace of mind that their sanitizing regimen will do more than a one-time kill of germs, by way of providing an additional important benefit of long-lasting protection from re-contamination."

CONTACT INFORMATION
info@choicewellnessbrands.com

Investors are encouraged to follow CYIOS using:
www.twitter.com/cyioscorp
www.linkedin.com/company/cyios-corporation-llc
www.facebook.com/cyioscorporation

About ChoiceWellness, Inc:

ChoiceWellness, Inc. is a health and wellness company that has brought to market the DR's CHOICE line of products, as well as the "24" Brand Hand Sanitizer products. DR's CHOICE was developed with a mission to offer Doctors and Medical Practitioners their own Professional Grade CBD BRAND with a suite of products they could stand behind and be confident to offer to their patients. Our customers can be assured that DR's CHOICE CBD products have gone through the highest scrutiny of testing for purity, potency and quality. DR's Choice products have been brought to market for Doctors and Medical Professionals seeking a better solution for patients suffering from pain, inflammation, anxiety or other persistent symptoms. For more information please visit www.choicewellnessbrands.com

About CYIOS Corporation:

CYIOS Corporation is a publicly traded company focused developing and marketing specialty branded products in the Health and Wellness markets, including the "DR's CHOICE" and "24" brand of products. The team has in-depth knowledge of the health and wellness markets, financial services industry, medical and health services, and blockchain. The Company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. Further, the Company continues to seek and evaluate attractive business opportunities and to leverage its resources and expertise to build a diversified, sustainable business model. For more information please visit www.cyioscorporation.com

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58209

https://www.newsfilecorp.com/newsinfo/58209/130

Cyios Corporation (CYIO) Stock Research Links

CYIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Brady Corporation to Host Earnings Conference Call

Updated Category News Views 55

Brady Corporation to Host Earnings Conference Call Brady Corporation (NYSE: BRC) is preparing to release its financial results for the fourth quarter of fiscal 2024 on an upcoming Friday. This important announcement will give stakeholders a clear view of the company's performance during this period. Details of the Earnings Conference Call The earnings conference call is...

Continue Reading
Johnson Fistel Probes Baldwin Insurance Group Over Financial Concerns

Updated Category News Views 97

Investigation Launched into Baldwin Insurance Group Leading law firm Johnson Fistel, LLP has embarked on an important investigation focusing on Baldwin Insurance Group, Inc. (NASDAQ: BWIN) concerning potential breaches in securities laws. This inquiry is prompted by serious allegations raised by a financial analysis firm regarding Baldwin’s financial practices. Concerns...

Continue Reading
InspireMD's Milestone $58 Million Financing Fuels Growth

Updated Category News Views 167

InspireMD Raises $58 Million Through Financing In a significant move to bolster its expansion into the United States market, InspireMD, Inc. (NASDAQ: NSPR), a pioneering developer of innovative carotid stenting technology, has successfully secured approximately $58 million in combined gross proceeds. This funding comes through an equity private placement and the exercise...

Continue Reading
Orion180 Partners with Vexcel for Enhanced Insurance Operations

Updated Category News Views 71

Enhancing Insurance Solutions with Vexcel Orion180 is making significant strides in the insurance industry by enhancing its underwriting and claims operations through a strategic partnership with Vexcel Data Program. This collaboration enables Orion180 to access high-resolution aerial imagery and sophisticated property analytics that are essential for effective real-time...

Continue Reading
AS Tallink Grupp’s Q3 2024 Report: Insights and Financials

Updated Category News Views 179

Overview of AS Tallink Grupp’s Q3 2024 Financial Performance The latest financial results for AS Tallink Grupp reveal a challenging yet insightful third quarter, reflecting the impact of global economic conditions and consumer behaviors. The Q3 2024 results were presented during an investor webinar where participants had the opportunity to engage and ask pertinent...

Continue Reading